Bank Of New York Mellon Corp Argenx Se Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$334.23 - $403.65 $1.22 Million - $1.48 Million	3,661 New	3,661 $1.36 Billion
Q4 2022 Feb 14, 2023	BUY	$342.17 - $402.31 $1.27 Million - $1.49 Million	3,707 New	3,707 $1.4 Million
Q3 2022 Nov 14, 2022	SELL	$343.2 - $395.75 $385,756 - $444,823	-1,124 Reduced 20.09%	4,470 $1.58 Million
Q2 2022 Aug 15, 2022	SELL	$269.58 - $378.88 $229,951 - $323,184	-853 Reduced 13.23%	5,594 $2.12 Million
Q1 2022 May 11, 2022	BUY	$254.45 - $351.06 $68,955 - $95,137	271 Added 4.39%	6,447 $2.03 Million
Q4 2021 Feb 11, 2022	BUY	$272.01 - $353.03 $529,603 - $687,349	1,947 Added 46.04%	6,176 $2.16 Million
Q3 2021 Nov 12, 2021	BUY	$295.0 - $350.58 $101,775 - $120,950	345 Added 8.88%	4,229 $1.28 Million
Q2 2021 Aug 11, 2021	SELL	$257.11 - $319.92 $98,987 - $123,169	-385 Reduced 9.02%	3,884 $1.17 Million
Q1 2021 May 13, 2021	SELL	$268.3 - $380.31 $367,034 - $520,264	-1,368 Reduced 24.27%	4,269 $1.18 Million
Q4 2020 Feb 09, 2021	SELL	$248.13 - $308.36 $47,889 - $59,513	-193 Reduced 3.31%	5,637 $1.66 Million
Q3 2020 Nov 12, 2020	SELL	$215.51 - $272.51 $268,309 - $339,274	-1,245 Reduced 17.6%	5,830 $1.53 Million
Q2 2020 Aug 12, 2020	BUY	$127.44 - $232.72 $4,715 - $8,610	37 Added 0.53%	7,075 $1.59 Million
Q1 2020 May 06, 2020	SELL	$108.83 - $165.23 $90,328 - $137,140	-830 Reduced 10.55%	7,038 $927,000
Q4 2019 Feb 14, 2020	BUY	$106.59 - $164.21 $223,412 - $344,184	2,096 Added 36.31%	7,868 $1.26 Million
Q3 2019 Nov 07, 2019	SELL	$113.31 - $150.51 $159,427 - $211,767	-1,407 Reduced 19.6%	5,772 $657,000
Q2 2019 Aug 12, 2019	SELL	$115.0 - $141.58 $21,620 - $26,617	-188 Reduced 2.55%	7,179 $1.02 Million
Q1 2019 May 14, 2019	BUY	$98.85 - $134.59 $143,826 - $195,828	1,455 Added 24.61%	7,367 $920,000
Q4 2018 Feb 11, 2019	SELL	$63.81 - $109.82 $313,881 - $540,204	-4,919 Reduced 45.42%	5,912 $568,000
Q3 2018 Nov 09, 2018	BUY	$75.5 - $96.63 $9,211 - $11,788	122 Added 1.14%	10,831 $0
Q2 2018 Aug 06, 2018	BUY	$74.84 - $100.16 $23,350 - $31,249	312 Added 3.0%	10,709 $887,000
Q1 2018 May 15, 2018	SELL	$56.95 - $85.19 $226,717 - $339,141	-3,981 Reduced 27.69%	10,397 $836,000
Q4 2017 Feb 09, 2018	BUY	$22.57 - $63.56 $324,511 - $913,865	14,378	14,378 $908,000

Others Institutions Holding ARGX

# of Institutions

400

Shares Held

30.9M

Call Options Held

376K

Put Options Held

489K

Price T Rowe Associates Inc Baltimore, MD

5.82M
Shares

$3.28 Billion
0.36% of portfolio
Artisan Partners Limited Partnership Milwaukee, WI

3.51M
Shares

$1.98 Billion
2.99% of portfolio
Janus Henderson Group PLC London, X0

2.48M
Shares

$1.4 Billion
0.72% of portfolio
Capital World Investors Los Angeles, CA

1.7M
Shares

$959 Million
0.15% of portfolio
Avoro Capital Advisors LLC New York, NY

1.24M
Shares

$699 Million
10.11% of portfolio

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $31.2B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account